RECRUITING

Optimizing CBSST with Executive Function Training for Schizophrenia

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study to test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). The aims include determining whether E-CBSST is feasible and increases Cognitive Behavioral Social Skills Training (CBSST) Skills Learning to a level that will lead to a clinically meaningful improvement in functioning.

Official Title

Optimizing Cognitive Behavioral Social Skills Training with Executive Function Training for Older Adults with Schizophrenia

Quick Facts

Study Start:2024-03-20

Study Completion:2025-11-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06251193

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Voluntary informed consent to participate; 2. Age 60 years or older; 3. DSM-5 diagnosis of schizophrenia or schizoaffective disorder based on the SCID; 4. Be clinically stable as operationalized by (1) not having been admitted to a psychiatric hospital within the three months prior to assessment, (2) having had no change in antipsychotic medication dosage within four weeks prior to the baseline assessment, and (3) and ascertained to be clinically and medically stable by one the study investigators; 5. Be willing and able to speak English; 6. Be able to read and converse (with corrected vision or hearing if needed).	1. Meets criteria for a cognitive disorder or for a neurological or other medical disorder affecting the ability to participate in Executive Function Training or CBSST; 2. Meets diagnostic criteria for bipolar disorder, current major depressive episode, or substance abuse or dependence within the six months prior to the baseline assessment except for caffeine or nicotine; 3. Received electroconvulsive therapy within six months of the baseline assessment.

Inclusion Criteria

Exclusion Criteria

1. Voluntary informed consent to participate;
2. Age 60 years or older;
3. DSM-5 diagnosis of schizophrenia or schizoaffective disorder based on the SCID;
4. Be clinically stable as operationalized by (1) not having been admitted to a psychiatric hospital within the three months prior to assessment, (2) having had no change in antipsychotic medication dosage within four weeks prior to the baseline assessment, and (3) and ascertained to be clinically and medically stable by one the study investigators;
5. Be willing and able to speak English;
6. Be able to read and converse (with corrected vision or hearing if needed).

1. Meets criteria for a cognitive disorder or for a neurological or other medical disorder affecting the ability to participate in Executive Function Training or CBSST;
2. Meets diagnostic criteria for bipolar disorder, current major depressive episode, or substance abuse or dependence within the six months prior to the baseline assessment except for caffeine or nicotine;
3. Received electroconvulsive therapy within six months of the baseline assessment.

Contacts and Locations

Study Contact

Jason Holden, PhD

CONTACT

858-246-2517

jlholden@health.ucsd.edu

Eric Granholm, PhD

CONTACT

858-534-2542

egranholm@health.ucsd.edu

Principal Investigator

Eric Granholm, PhD

PRINCIPAL_INVESTIGATOR

University of California, San Diego

Tarek Rajji, MD

PRINCIPAL_INVESTIGATOR

Centre for Addiction and Mental Health

Study Locations (Sites)

UC San Diego

La Jolla, California, 92093

United States

Collaborators and Investigators

Sponsor: University of California, San Diego

Eric Granholm, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego
Tarek Rajji, MD, PRINCIPAL_INVESTIGATOR, Centre for Addiction and Mental Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-20

Study Completion Date2025-11-30

Study Record Updates

Study Start Date2024-03-20

Study Completion Date2025-11-30

Terms related to this study

Additional Relevant MeSH Terms

Schizophrenia
Schizoaffective Disorder